Filter
98
Text search:
Shigella
Featured
Recommendations
11
New Publications
22
Language
Document type
No document type
46
Guidelines
20
Studies & Reports
13
Manuals
6
Strategic & Response Plan
4
Fact sheets
4
Training Material
3
Situation Updates
2
Countries / Regions
Ethiopia
5
Rwanda
4
Nigeria
3
South Africa
3
Bangladesh
3
Latin America and the Carribbean
3
Western and Central Europe
3
Sierra Leone
2
Congo, Democratic Republic of
2
India
2
Nepal
2
Germany
2
Tanzania
2
Africa
2
Global
2
Liberia
1
Senegal
1
Mali
1
Ghana
1
Zimbabwe
1
Jordan
1
Kenya
1
Indonesia
1
Malawi
1
Brazil
1
North Macedonia
1
Colombia
1
Myanmar / Burma
1
Russia
1
Iran
1
Vietnam
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
31
Clinical Guidelines
16
Key Resources
13
Women & Child Health
11
Capacity Building
5
Pharmacy & Technologies
4
Public Health
3
Toolboxes
AMR
19
Rapid Response
11
Cholera
9
Pharmacy
7
Ebola & Marburg
3
Natural Hazards
3
HIV
3
Caregiver
3
2.0 Rapid Response
3
TB
2
COVID-19
2
Planetary Health
2
NTDs
2
Polio
1
Conflict
1
Refugee
1
Mental Health
1
Global Health Education
1
Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater and exacerbated by limited access to, and availability and affordability of, antimicrobials required to treat infect
...
5th revised edition.
This document provides a ranking of medically important antimicrobials for risk management of antimicrobial resistance due to non-human use. The current revision took place at the seventh meeting of the AGISAR held in Raleigh, United States of America in 2016.
BUKO Pharma-Kampagne has investigated the causes and consequences of antibiotic resistance in India, South Africa, Tanzania and Germany. Together with our partners we collected data and did interviews with numerous stakeholders. The outcome is presented in a brochure that is now available in English
...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these
...
Diese Broschüre möchte dazu beitragen, dass möglichst viele Menschen die Ergebnisse öffentlich finanzierter Forschung nutzen können.
Antibiotics and other antimicrobial agents are invaluable life savers, particularly in resource-limited countries where infectious diseases are abundant. Both uncomplicated and severe infections are potentially curable as long as the aetiological agents are susceptible to the
...
There is a broad consensus nowadays that the Earth is warming up as a result of greenhouse gas emissions caused by anthropogenic activities. It is also clear that current trends in the fields of energy, development and population growth will lead to continuous and ever more dramatic climate change.
...
La mayoría de los objetivos son objetivos de comportamiento escritos como declaraciones de acción. Éstas son las prácticas que esperamos que los cuidadores adopten y mantengan en base a los mensajes claves en el rotafolio
Handbook of Foodborne Pathogenic Microorganisms and Natural Toxins
Technical Guidelines for Integrated Disease Surveillance and Response in the African Region
recommended
3rd edition.
The third edition of the Integrated Disease Surveillance and Response (IDSR) Technical Guidelines was prepared by the WHO Health Emergencies (WHE) Programme with the active participation and involvement of programmes dealing with disease surveillance at the WHO Regional Office for Afri
...
Public Health Situation Analysis and Interventions 10 October 2017
РУКОВОДСТВО ПО ВЕДЕНИЮ НАИБОЛЕЕ РАСПРОСТРАНЕННЫХ БОЛЕЗНЕЙ ДЕТСКОГО ВОЗРАСТА
Второе издание
Данная публикация является вторым изданием Карманного справочника
...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these
...
